{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.35",
    "chg": 3.25,
    "chgp": "4.99%",
    "dir": 1,
    "prev_price": "65.10",
    "mcapval": "371.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0JWS01017",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "33.18 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-valuation-shifts-signal-heightened-price-risk-3997935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_valuationdot_3997935.png",
        "date": "2026-05-19 08:02:54",
        "description": "Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons."
      }
    ],
    "total": 15,
    "sid": "10039033",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Financial Results For Quarter Ended June 30 2026",
      "datetime": "05-Aug-2026",
      "details": "Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve financial results for Quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jul-2026",
      "details": "for quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Closure of Trading Window for declaration of Financial Results for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk

2026-05-19 08:02:54

Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons.

Read More

View All News